← Leaderboards
James Joseph Prisciandaro
Medical University Of South Carolina
$8,640,417
Attributed
$8,640,417
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,640,417 · 7
By mechanism
R01$5,763,845 · 2
P50$933,015 · 1
K23$834,564 · 1
K24$645,102 · 1
R21$411,125 · 1
F32$52,766 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Raymond F Anton$17,048,886
- Kevin M Gray$28,834,568
- Erin A McClure$9,972,633
- Lindsay Squeglia$10,315,385
- Mark A Eckert$9,774,452
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsBrainProtonsGlutamatesMagnetic Resonance SpectroscopyFunctional Magnetic Resonance ImagingNeuroimagingInvestigationNeurochemistryMagnetic Resonance ImagingParticipantGamma-Aminobutyric AcidDiagnosisAlcohol CueResponseCue ReactivityAnteriorPlacebosFda ApprovedBipolar DisorderBrain RegionFundingCorpus Striatum StructureGabapentin
Grant awards (27)
Gabapentin for Restoring GABA/glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Clinical MRI Study$607,484
R01 · FY2025 · DA · contact PI
Mentorship and Research in Bipolar and Substance Use Disorders$215,034
K24 · FY2025 · AA · contact PI
Effects of a Novel mGluR5 Negative Allosteric Modulator on Alcohol Drinking, Neurochemistry, and Brain Reactivity to Alcohol Cues in Alcohol Use Disorder$165,989
P50 · FY2025 · AA · contact PI
Gabapentin for Restoring GABA/glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Clinical MRI Study$624,444
R01 · FY2024 · DA · contact PI
Mentorship and Research in Bipolar and Substance Use Disorders$215,034
K24 · FY2024 · AA · contact PI
Effects of a Novel mGluR5 Negative Allosteric Modulator on Alcohol Drinking, Neurochemistry, and Brain Reactivity to Alcohol Cues in Alcohol Use Disorder$190,646
P50 · FY2024 · AA · contact PI
Gabapentin for Restoring GABA/glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Clinical MRI Study$624,446
R01 · FY2023 · DA · contact PI
Mentorship and Research in Bipolar and Substance Use Disorders$215,034
K24 · FY2023 · AA · contact PI
Effects of a Novel mGluR5 Negative Allosteric Modulator on Alcohol Drinking, Neurochemistry, and Brain Reactivity to Alcohol Cues in Alcohol Use Disorder$192,005
P50 · FY2023 · AA · contact PI
Gabapentin for Restoring GABA/glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Clinical MRI Study$624,446
R01 · FY2022 · DA · contact PI
Effects of a Novel mGluR5 Negative Allosteric Modulator on Alcohol Drinking, Neurochemistry, and Brain Reactivity to Alcohol Cues in Alcohol Use Disorder$188,349
P50 · FY2022 · AA · contact PI
Imaging Framework for Testing GABAergic Drugs in Bipolar Alcoholics$148,995
R01 · FY2022 · AA · contact PI
Gabapentin for Restoring GABA/glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Clinical MRI Study$622,551
R01 · FY2021 · DA · contact PI
Imaging Framework for Testing GABAergic/glutamatergic Drugs in Bipolar Alcoholics$520,616
R01 · FY2021 · AA · contact PI
Effects of a Novel mGluR5 Negative Allosteric Modulator on Alcohol Drinking, Neurochemistry, and Brain Reactivity to Alcohol Cues in Alcohol Use Disorder$196,026
P50 · FY2021 · AA · contact PI
Imaging Framework for Testing GABAergic/glutamatergic Drugs in Bipolar Alcoholics$513,626
R01 · FY2020 · AA · contact PI
Imaging Framework for Testing GABAergic/glutamatergic Drugs in Bipolar Alcoholics$511,635
R01 · FY2019 · AA · contact PI
Imaging Framework for Testing GABAergic/glutamatergic Drugs in Bipolar Alcoholics$484,846
R01 · FY2018 · AA · contact PI
Gabapentin for Bipolar & Cannabis Use Disorders: Relation to Brain GABA/Glutamate$186,875
R21 · FY2018 · DA · contact PI
Imaging Framework for Testing GABAergic/glutamatergic Drugs in Bipolar Alcoholics$480,756
R01 · FY2017 · AA · contact PI
Gabapentin for Bipolar & Cannabis Use Disorders: Relation to Brain GABA/Glutamate$224,250
R21 · FY2017 · DA · contact PI
Neuroimaging mechanisms of overlap between alcoholism and bipolar disorder$170,319
K23 · FY2016 · AA · contact PI
Neuroimaging mechanisms of overlap between alcoholism and bipolar disorder$170,319
K23 · FY2015 · AA · contact PI
Neuroimaging mechanisms of overlap between alcoholism and bipolar disorder$165,210
K23 · FY2014 · AA · contact PI
Neuroimaging mechanisms of overlap between alcoholism and bipolar disorder$158,397
K23 · FY2013 · AA · contact PI
Neuroimaging mechanisms of overlap between alcoholism and bipolar disorder$170,319
K23 · FY2012 · AA · contact PI
fMRI of cue-reactivity and impulsivity in recreational vs dependent cocaine users$52,766
F32 · FY2011 · DA · contact PI